JP2006502250A5 - - Google Patents

Download PDF

Info

Publication number
JP2006502250A5
JP2006502250A5 JP2004525225A JP2004525225A JP2006502250A5 JP 2006502250 A5 JP2006502250 A5 JP 2006502250A5 JP 2004525225 A JP2004525225 A JP 2004525225A JP 2004525225 A JP2004525225 A JP 2004525225A JP 2006502250 A5 JP2006502250 A5 JP 2006502250A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004525225A
Other languages
English (en)
Japanese (ja)
Other versions
JP4451308B2 (ja
JP2006502250A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/007736 external-priority patent/WO2004012773A1/en
Publication of JP2006502250A publication Critical patent/JP2006502250A/ja
Publication of JP2006502250A5 publication Critical patent/JP2006502250A5/ja
Application granted granted Critical
Publication of JP4451308B2 publication Critical patent/JP4451308B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004525225A 2002-07-24 2003-07-16 ポリアルキレングリコール酸添加剤 Expired - Fee Related JP4451308B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39813702P 2002-07-24 2002-07-24
PCT/EP2003/007736 WO2004012773A1 (en) 2002-07-24 2003-07-16 Polyalkylene glycol acid additives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008182692A Division JP5112203B2 (ja) 2002-07-24 2008-07-14 ポリアルキレングリコール酸添加剤

Publications (3)

Publication Number Publication Date
JP2006502250A JP2006502250A (ja) 2006-01-19
JP2006502250A5 true JP2006502250A5 (enExample) 2008-09-04
JP4451308B2 JP4451308B2 (ja) 2010-04-14

Family

ID=31495718

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004525225A Expired - Fee Related JP4451308B2 (ja) 2002-07-24 2003-07-16 ポリアルキレングリコール酸添加剤
JP2008182692A Expired - Fee Related JP5112203B2 (ja) 2002-07-24 2008-07-14 ポリアルキレングリコール酸添加剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008182692A Expired - Fee Related JP5112203B2 (ja) 2002-07-24 2008-07-14 ポリアルキレングリコール酸添加剤

Country Status (13)

Country Link
US (2) US7193031B2 (enExample)
EP (1) EP1526872A1 (enExample)
JP (2) JP4451308B2 (enExample)
KR (1) KR100608415B1 (enExample)
CN (1) CN100337689C (enExample)
AR (1) AR040654A1 (enExample)
AU (1) AU2003258518B2 (enExample)
BR (1) BR0313212A (enExample)
CA (1) CA2492775C (enExample)
MX (1) MXPA05000796A (enExample)
PL (1) PL375265A1 (enExample)
RU (1) RU2318004C2 (enExample)
WO (1) WO2004012773A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
DK2311432T3 (en) 2002-06-07 2015-02-02 Dyax Corp Modified Kunitz domain polypeptides and their use in reducing ischemia or the onset of a systemic inflammatory response associated with a surgical procedure
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
CN100337689C (zh) * 2002-07-24 2007-09-19 弗·哈夫曼-拉罗切有限公司 聚亚烷基二醇酸加合物
AU2004268144A1 (en) * 2003-08-29 2005-03-10 Dyax Corp. Modified protease inhibitors
AU2004268145B2 (en) * 2003-08-29 2010-09-16 Takeda Pharmaceutical Company Limited Poly-PEGylated protease inhibitors
WO2005089805A2 (en) * 2004-03-15 2005-09-29 Nektar Therapeutics Al, Corporation Polymer-based compositions and conjugates of hiv entry inhibitors
EP1753805A4 (en) * 2004-05-17 2009-11-25 Univ Mcmaster AGAINST BIOLOGICAL MOLECULES REACTIVE HYDROPHILIC SILICONE SURFACE
US20060036080A1 (en) 2004-07-16 2006-02-16 Bossard Mary J Conjugates of GM-CSF moiety and a polymer
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
EP2045282B1 (en) * 2005-08-26 2011-03-23 Novo Nordisk A/S A method of modifying a macromolecular system
DE602006005686D1 (de) * 2005-08-26 2009-04-23 Novo Nordisk As Verfahren zur modifizierung eines makromolekularen systems
US8133707B2 (en) * 2006-01-17 2012-03-13 Enzon Pharmaceuticals, Inc. Methods of preparing activated polymers having alpha nitrogen groups
CL2008002054A1 (es) 2007-07-17 2009-05-29 Hoffmann La Roche Metodo para la regeneracion de una columna de cromatografia de intercambio cationico despues de la elusion de eritropoyetina monopeguilada y metodo para obtener una eritropoyetina monopeguilada, incorporando el metodo de regeneracion de la columna de intercambio cationico.
CL2008002053A1 (es) 2007-07-17 2009-05-22 Hoffmann La Roche Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
WO2009026334A2 (en) * 2007-08-21 2009-02-26 Genzyme Corporation Treatment with kallikrein inhibitors
US8637466B2 (en) 2008-08-11 2014-01-28 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
US8637454B2 (en) 2009-01-06 2014-01-28 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
ES2688093T3 (es) 2010-01-06 2018-10-30 Dyax Corp. Proteínas de unión a calicreína plasmática
US10040761B2 (en) * 2010-06-25 2018-08-07 Nof Corporation Branched hetero polyethylene glycol and intermediate
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
IL269565B2 (en) 2011-01-06 2024-06-01 Dyax Corp Plasma kallikrein binding proteins
JP2015514718A (ja) 2012-04-03 2015-05-21 サンガート, インコーポレイテッド スクシンイミド活性化されたニトロキシル化合物およびタンパク質のニトロキシル化のためのその使用のための方法
CN102816227A (zh) * 2012-08-30 2012-12-12 深圳赛保尔生物药业有限公司 回收促红细胞生成素的方法
MX373193B (es) 2013-03-15 2020-05-07 Sangart Inc Conjugados de hemoglobina óxido de polialquileno valerato.
EP3122782A4 (en) 2014-03-27 2017-09-13 Dyax Corp. Compositions and methods for treatment of diabetic macular edema
BR112018011622A2 (pt) 2015-12-11 2018-11-27 Dyax Corp método para tratar ataque de angioedema hereditário (hae) ou reduzir a taxa de ataque de hae
EP3950783B1 (en) * 2019-03-29 2023-11-08 NOF Corporation Method for producing terminal carboxyl group-containing polyethylene glycol and method for producing activated polyethylene glycol
CA3167336A1 (en) 2020-01-13 2021-07-22 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating pediatric hereditary angioedema attack

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5849450B2 (ja) * 1975-07-09 1983-11-04 株式会社日立製作所 スイリヨクシキカプセルユソウソウチノ ボウシクホウ
DE3675588D1 (de) 1985-06-19 1990-12-20 Ajinomoto Kk Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
JP2531661B2 (ja) 1987-02-25 1996-09-04 味の素株式会社 酸素運搬剤
US5595732A (en) 1991-03-25 1997-01-21 Hoffmann-La Roche Inc. Polyethylene-protein conjugates
US5382657A (en) 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
DE69430251T2 (de) * 1993-11-10 2002-11-07 Enzon, Inc. Verbesserte interferon-polymerkonjugate
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
TW517067B (en) 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
DE69735292T2 (de) * 1996-10-25 2006-10-19 Gilead Sciences, Inc., Foster City Gefaesszellen wachstumsfaktor (vegf) nukleinsäureligand-komplexe
HK1049673A1 (zh) 1999-01-29 2003-05-23 霍夫曼-拉罗奇有限公司 Gcsf缀合物
AU3714800A (en) 1999-03-02 2000-09-21 Schering Corporation Hiv therapy
CZ299516B6 (cs) 1999-07-02 2008-08-20 F. Hoffmann-La Roche Ag Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
BR9917517A (pt) 1999-10-08 2002-07-30 Shearwater Corp Derivados poliméricos heterobifuncionais e processo para a preparação dos mesmos
DE60026073T2 (de) * 1999-12-22 2006-09-28 Nektar Therapeutics Al, Corp., Huntsville Sterisch gehinderte derivate von wasserlöslichen polymeren
US20020065397A1 (en) 2000-10-12 2002-05-30 Joseph Roberts Protecting therapeutic compositions from host-mediated inactivation
DE60144439D1 (de) * 2000-12-20 2011-05-26 Hoffmann La Roche Konjugate von erythropoietin (epo) mit polyethylenglykol (peg)
CN100337689C (zh) * 2002-07-24 2007-09-19 弗·哈夫曼-拉罗切有限公司 聚亚烷基二醇酸加合物

Similar Documents

Publication Publication Date Title
JP2007515381A5 (enExample)
JP2006028409A5 (enExample)
JP2006503960A5 (enExample)
JP2005247844A5 (enExample)
JP2007063520A5 (enExample)
JP2006514019A5 (enExample)
JP2004244619A5 (enExample)
JP2006188651A5 (enExample)
JP2004168997A5 (enExample)
JP2005533836A5 (enExample)
JP2003305787A5 (enExample)
JP2008514623A5 (enExample)
JP2006028280A5 (enExample)
JP2006510481A5 (enExample)
JP2005523387A5 (enExample)
JP2004262980A5 (enExample)
JP2007070320A5 (enExample)
JP2005206527A5 (enExample)
JP2002508090A5 (enExample)
JP2005035984A5 (enExample)
JP2005506321A5 (enExample)
JP2005002267A5 (enExample)
JP2004294750A5 (enExample)
JP2006233098A5 (enExample)
JP2005503339A5 (enExample)